Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden

NCT00651937 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Primary Amyloidosis

Interventions

DRUG: Melphalan
PROCEDURE: Stem Cell Infusion
BEHAVIORAL: Questionnaires
DRUG: Granulocyte-colony stimulating factor (G-CSF)
PROCEDURE: Apheresis

Sponsor

M.D. Anderson Cancer Center